Cardiovascular device manufacturer scaling manufacturing and global commercial operations
Cordis manufactures and markets interventional cardiovascular devices across a global footprint. The hiring mix is heavily weighted toward sales (110 roles) and manufacturing (27), with engineering and product teams undersized relative to active manufacturing transitions — signaling a company in commercial scaling mode rather than R&D acceleration. Active projects confirm this: US commercial launches of new devices (mynx venous closure), process optimization, and MES documentation improvements dominate the roadmap, while pain points cluster around revenue growth, account penetration, and inventory control.
Cordis is a cardiovascular device manufacturer based in Miami Lakes, FL, with operations across 20+ countries. The company designs and manufactures interventional products including guidewires and drug-eluting stents, sold to hospitals and interventional centers through a direct sales channel. With 1,001–5,000 employees globally, Cordis runs a complex manufacturing operation (processing microsphere batches, qualifying new equipment) while managing concurrent product launches and transitioning designs into full-rate production. The tech stack reflects a traditional medical-device operations footprint: SAP and JD Edwards for ERP, ServiceNow for case management, Salesforce for CRM, and Power BI/Tableau for analytics.
Cordis uses SAP and JD Edwards EnterpriseOne for enterprise resource planning, Salesforce for CRM, ServiceNow for case workflows, Power BI and Tableau for analytics, and SolidWorks for product design. MES (Manufacturing Execution System) and Wonderware support floor-level operations.
Cordis is headquartered in Miami Lakes, Florida, and operates manufacturing and commercial facilities across the United States, Europe, Asia, and Latin America.
Other companies in the same industry, closest in size